Aripiprazol Pliva 30 mg tablete
Name | Aripiprazol Pliva 30 mg tablete |
---|---|
Marketing Authorisation Number | HR-H-654548929 |
Active Substance | aripiprazol |
Composition | svaka tableta sadrži 30 mg aripiprazola |
Pharmaceutical Form | tableta |
Manufacturer | Merckle GmbH, Blaubeuren, Njemačka Teva Pharma B.V., Haarlem, Nizozemska Pliva Hrvatska d.o.o., Zagreb, Hrvatska Teva Operations Poland Sp. z o.o., Krakow, Poljska PharmaPath S.A., Agia, Varvara, Grčka Actavis Limited, Zejtun, Malta |
Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
Marketing Authorisation Date | 08.05.2019 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/19-02/07 |
Registration Number | 381-12-01/30-19-03 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ponovljivi recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | N05AX12 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Public Assessment Report | download |